Non-covalent ligand/DNA interactions: minor groove binding agents.

An understanding of the mechanism by which minor groove binding agents interact with DNA has led to the design of agents that can reversibly bind with high selectivity to extended DNA target sequences. Simple compounds, such as the polypyrroles and the bis-benzimidazoles, have been used as carriers for alkylating agents effectively directing alkylation to specific DNA sequences. The spectrum of DNA alkylation and mutation by classical alkylators, such as nitrogen mustards, has been profoundly modified by such attachment. The observed "side-by-side" binding of small polypyrrole antibiotics has led to the design of synthetic hairpin polyamides with programmable DNA sequence selectivity. These compounds are able to compete with natural substrates, such as specific transcription factors, and alter gene expression. They are being developed as artificial transcription factors, able to deliver activating peptides to specific recognition sequences, and as potential protein-DNA dimerization agents. Hairpin polyamides are also being used as carriers for the delivery of alkylators to defined DNA sites. The degree of control of gene expression thus offered by the hairpin polyamides suggests enormous promise for their clinical utility. Recent developments with other minor groove binding small molecules and technological advances are also discussed.

[1]  P. Dervan,et al.  Programmable oligomers targeting 5'-GGGG-3' in the minor groove of DNA and NF-kappaB binding inhibition. , 2007, Bioorganic & medicinal chemistry.

[2]  Dale L Boger,et al.  Sequence-selective DNA recognition: natural products and nature's lessons. , 2004, Chemistry & biology.

[3]  J. Lah,et al.  Energetic diversity of DNA minor-groove recognition by small molecules displayed through some model ligand-DNA systems. , 2004, Journal of molecular biology.

[4]  K. Bielawski,et al.  Synthesis, DNA binding, topoisomerase inhibition and cytotoxic properties of 2-chloroethylnitrosourea derivatives of hoechst 33258. , 2005, Biological & pharmaceutical bulletin.

[5]  P. Dervan,et al.  Cell-free and Cellular Activities of a DNA Sequence Selective Hairpin Polyamide-CBI Conjugate* , 2002, The Journal of Biological Chemistry.

[6]  P. Baraldi,et al.  DNA minor groove binders as potential antitumor and antimicrobial agents , 2004, Medicinal research reviews.

[7]  Aklank Jain,et al.  Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapy , 2006, Nucleic acids research.

[8]  Binh Nguyen,et al.  Design of a Hairpin Polyamide, ZT65B, for Targeting the Inverted CCAAT Box (ICB) Site in the Multidrug Resistant (MDR1) Gene , 2005, Chembiochem : a European journal of chemical biology.

[9]  P. Dervan,et al.  Toward artificial developmental regulators. , 2003, Journal of the American Chemical Society.

[10]  L. EdwardsMichael,et al.  Synthesis and DNA-binding properties of polyamine analogues. , 1991 .

[11]  C. Wang,et al.  Expanding the recognition of the minor groove of DNA by incorporation of beta-alanine in hairpin polyamides. , 2001, Bioorganic & medicinal chemistry.

[12]  P. Dervan,et al.  Recognition of the DNA minor groove by pyrrole-imidazole polyamides. , 2003, Current opinion in structural biology.

[13]  P. Dervan,et al.  Accessibility of nuclear chromatin by DNA binding polyamides. , 2003, Chemistry & biology.

[14]  D. Paslier,et al.  Human Chromosomal Fragile Site FRA16B Is an Amplified AT-Rich Minisatellite Repeat , 1997, Cell.

[15]  M. N. Gupta,et al.  The affinity concept in bioseparation: evolving paradigms and expanding range of applications. , 2006, Biomolecular engineering.

[16]  B. Gatto,et al.  DNA minor groove-binding ligands: a different class of mammalian DNA topoisomerase I inhibitors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[17]  A. Shimamoto,et al.  Quantitative analysis of Werner helicase activity using the single-molecule fluorescence detection system MF10S. , 2005, Biological & pharmaceutical bulletin.

[18]  P. Dervan,et al.  Nuclear localization of pyrrole–imidazole polyamide–fluorescein conjugates in cell culture , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[19]  T. Hsu,et al.  Induction of high frequencies of endoreduplication in mammalian cell cultures with 33258 Hoechst and rubidazone. , 1979, Cytogenetics and Cell Genetics.

[20]  W. Wilson,et al.  Dications that target the DNA minor groove: compound design and preparation, DNA interactions, cellular distribution and biological activity. , 2005, Current medicinal chemistry. Anti-cancer agents.

[21]  J. Trauger,et al.  Inhibition of Ets-1 DNA Binding and Ternary Complex Formation between Ets-1, NF-κB, and DNA by a Designed DNA-binding Ligand* , 1999, The Journal of Biological Chemistry.

[22]  Suman Das,et al.  Association of chromatin with anticancer antibiotics, mithramycin and chromomycin A3. , 2003, Bioorganic & medicinal chemistry.

[23]  G. Sutherland,et al.  Heritable fragile sites on human chromosomes. XI. Factors affecting expression of fragile sites at 10q25, 16q22, and 17p12. , 1984, American journal of human genetics.

[24]  W. Denny,et al.  Potential antitumor agents. 34. Quantitative relationships between DNA binding and molecular structure for 9-anilinoacridines substituted in the anilino ring. , 1981, Journal of medicinal chemistry.

[25]  M. Sabatino,et al.  Enhancement of in vivo antitumor activity of classical anticancer agents by combination with the new, glutathione-interacting DNA minor groove-binder, brostallicin. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[26]  D. Dasgupta,et al.  Interaction of antitumor drug, mithramycin, with chromatin. , 2001, Biochemical and biophysical research communications.

[27]  W. Denny,et al.  DNA and the chromosome – varied targets for chemotherapy , 2004, Cell & chromosome.

[28]  K. Luger,et al.  Sequence-specific recognition of DNA in the nucleosome by pyrrole-imidazole polyamides. , 2001, Journal of molecular biology.

[29]  M. McHugh,et al.  Modulation of topoisomerase II catalytic activity by DNA minor groove binding agents distamycin, Hoechst 33258, and 4',6-diamidine-2-phenylindole. , 1989, Molecular pharmacology.

[30]  K. Bielawski,et al.  Synthesis, DNA-binding activity and cytotoxicity of carbamate derivatives of Hoechst 33258 in breast cancer MCF-7 cells. , 2002, Biological & pharmaceutical bulletin.

[31]  D. Goodsell Sequence recognition of DNA by lexitropsins. , 2001, Current medicinal chemistry.

[32]  P. Wright,et al.  Inhibition of DNA binding by human estrogen-related receptor 2 and estrogen receptor alpha with minor groove binding polyamides. , 2005, Biochemistry.

[33]  P. Dervan,et al.  Promoter Scanning for Transcription Inhibition with DNA-Binding Polyamides , 2002, Molecular and Cellular Biology.

[34]  Peter B. Dervan,et al.  Regulation of gene expression by small molecules , 1997, Nature.

[35]  G. Fronza,et al.  DNA damage and cytotoxicity induced by minor groove binding methyl sulfonate esters. , 2003, Biochemistry.

[36]  Souvik Maiti,et al.  Hoechst 33258 binds to G-quadruplex in the promoter region of human c-myc. , 2003, Biochemical and biophysical research communications.

[37]  R. Blattes,et al.  Target practice: aiming at satellite repeats with DNA minor groove binders. , 2005, Current medicinal chemistry. Anti-cancer agents.

[38]  K. Vékey,et al.  Combination of solid-phase affinity capture on magnetic beads and mass spectrometry to study non-covalent interactions: example of minor groove binding drugs. , 2005, Rapid communications in mass spectrometry : RCM.

[39]  D. Dasgupta,et al.  Association of anticancer drug mithramycin with H1-depleted chromatin: a comparison with native chromatin. , 2003, Journal of inorganic biochemistry.

[40]  J. Griffith,et al.  The [(G/C)3NN]n motif: a common DNA repeat that excludes nucleosomes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[41]  B. Gold,et al.  Groove- and sequence-selective alkylation of DNA by sulfonate esters tethered to lexitropsins. , 1993, Biochemistry.

[42]  J. Lown,,et al.  Netropsin and bis-netropsin analogs as inhibitors of the catalytic activity of mammalian DNA topoisomerase II and topoisomerase cleavable complexes. , 1991, Biochimica et biophysica acta.

[43]  P. Monti,et al.  Nucleotide excision repair defect influences lethality and mutagenicity induced by Me-lex, a sequence-selective N3-adenine methylating agent in the absence of base excision repair. , 2004, Biochemistry.

[44]  A. Inga,et al.  Influences of Base Excision Repair Defects on the Lethality and Mutagenicity Induced by Me-lex, a Sequence-selective N3-Adenine Methylating Agent* , 2002, The Journal of Biological Chemistry.

[45]  P. Dervan,et al.  A Two-Hit Mechanism for Pre-Mitotic Arrest of Cancer Cell Proliferation by a Polyamide-Alkylator Conjugate , 2006, Cell cycle.

[46]  W. Denny,et al.  The mutagenic properties of DNA minor-groove binding ligands. , 1996, Mutation research.

[47]  J. Petty,et al.  Hydration changes in the association of Hoechst 33258 with DNA. , 2005, Biochemistry.

[48]  W. Denny,et al.  DNA-directed alkylating agents. 6. Synthesis and antitumor activity of DNA minor groove-targeted aniline mustard analogues of pibenzimol (Hoechst 33258) , 1994, Journal of medicinal chemistry.

[49]  N. Maizels,et al.  Specific interactions of distamycin with G-quadruplex DNA. , 2003, Nucleic acids research.

[50]  J. Trauger,et al.  Minor groove DNA-protein contacts upstream of a tRNA gene detected with a synthetic DNA binding ligand. , 1999, Journal of molecular biology.

[51]  A. Wolffe,et al.  Nucleosome Assembly on Methylated CGG Triplet Repeats in the Fragile X Mental Retardation Gene 1 Promoter* , 1996, The Journal of Biological Chemistry.

[52]  W. Denny,et al.  Mono- and dysfunctional nitrogen mustard analogues of the DNA minor groove binder pibenzimol. Synthesis, cytotoxicity and interaction with DNA. , 1998, Anti-cancer drug design.

[53]  Yuh-Hwa Wang,et al.  Human Fragile Site FRA16B DNA Excludes Nucleosomes in the Presence of Distamycin* , 2002, The Journal of Biological Chemistry.

[54]  P. Aich,et al.  Role of Mg++ in the mithramycin-DNA interaction: evidence for two types of mithramycin-Mg++ complex. , 1990, Biochemical and biophysical research communications.

[55]  Aneel K. Aggarwal,et al.  Structure of a DNA-bound Ultrabithorax–Extradenticle homeodomain complex , 1999, Nature.

[56]  N. Taulier,et al.  Association of the minor groove binding drug Hoechst 33258 with d(CGCGAATTCGCG)2: volumetric, calorimetric, and spectroscopic characterizations. , 2005, Biochemistry.

[57]  K. Luger,et al.  Crystal structures of nucleosome core particles in complex with minor groove DNA-binding ligands. , 2003, Journal of molecular biology.

[58]  W. Denny,et al.  Structures of two minor-groove-binding quinolinium quaternary salts complexed with d(CGCGAATTCGCG)(2) at 1.6 and 1.8 Angstrom resolution. , 2005, Acta crystallographica. Section D, Biological crystallography.

[59]  Christopher L. Warren,et al.  Defining the sequence-recognition profile of DNA-binding molecules. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[60]  S. Awasthi,et al.  Triple helix stabilization by covalently linked DNA-bisbenzimidazole conjugate synthesized by maleimide-thiol coupling chemistry. , 2006, Bioorganic & medicinal chemistry.

[61]  P. Cozzi Recent outcome in the field of distamycin-derived minor groove binders. , 2000, Farmaco.

[62]  A. Mikheikin,et al.  Molecular Modelling of Ligand—DNA Minor Groove Binding: Role of Ligand—Water Interactions , 2001, Journal of Biomolecular Structure and Dynamics.

[63]  M. Singh,et al.  Synthesis and sequence-specific DNA binding of a topoisomerase inhibitory analog of Hoechst 33258 designed for altered base and sequence recognition. , 1992, Chemical research in toxicology.

[64]  K. Doherty,et al.  DNA helicases as targets for anti-cancer drugs. , 2005, Current medicinal chemistry. Anti-cancer agents.

[65]  P. Dervan,et al.  Binding affinities of synthetic peptides, pyridine-2-carboxamidonetropsin and 1-methylimidazole-2-carboxamidonetropsin, that form 2:1 complexes in the minor groove of double-helical DNA. , 1993, Biochemistry.

[66]  Suman Das,et al.  Binding of (MTR)2Zn2+ complex to chromatin: a comparison with (MTR)2Mg2+ complex. , 2005, Journal of inorganic biochemistry.

[67]  Koichi Matsumoto,et al.  Synthetic Pyrrole-Imidazole Polyamide Inhibits Expression of the Human Transforming Growth Factor-β1 Gene , 2005, Journal of Pharmacology and Experimental Therapeutics.

[68]  P. Dervan,et al.  Temperature-sensitive protein-DNA dimerizers. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[69]  R. Snyder,et al.  Mithramycin blocks transcriptional initiation of the c-myc P1 and P2 promoters. , 1991, Biochemistry.

[70]  C. Benz,et al.  Targeting the Ets Binding Site of the HER2/neuPromoter with Pyrrole-Imidazole Polyamides* , 2000, The Journal of Biological Chemistry.

[71]  M. McHugh,et al.  Effect of minor groove binding drugs on mammalian topoisomerase I activity. , 1989, Biochemical pharmacology.

[72]  P. Ghanouni,et al.  A DNA minor groove-binding ligand both potentiates and arrests transcription by RNA polymerase II. Elongation factor SII enables readthrough at arrest sites. , 1994, Journal of molecular biology.

[73]  P. Dervan,et al.  Small molecule transcription factor mimic. , 2004, Journal of the American Chemical Society.

[74]  K. Fox,et al.  Investigations into the sequence-selective binding of mithramycin and related ligands to DNA. , 1985, Nucleic acids research.

[75]  P. Dervan,et al.  Exploring the limits of benzimidazole DNA-binding oligomers for the hypoxia inducible factor (HIF) site. , 2006, Bioorganic & medicinal chemistry.

[76]  W. Denny DNA minor groove alkylating agents. , 2001, Current medicinal chemistry.

[77]  Sherry M. Tsai,et al.  Unanticipated differences between α- and γ-diaminobutyric acid-linked hairpin polyamide-alkylator conjugates , 2006, Nucleic acids research.

[78]  W. Denny,et al.  DNA-Directed alkylating agents. 7. Synthesis, DNA interaction, and antitumor activity of bis(hydroxymethyl)- and bis(carbamate)-substituted pyrrolizines and imidazoles. , 1998, Journal of medicinal chemistry.

[79]  A. Inga,et al.  Relationship between DNA Methylation and Mutational Patterns Induced by a Sequence Selective Minor Groove Methylating Agent* , 1999, The Journal of Biological Chemistry.

[80]  D. Wemmer,et al.  Antiparallel side-by-side dimeric motif for sequence-specific recognition in the minor groove of DNA by the designed peptide 1-methylimidazole-2-carboxamide netropsin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[81]  P. Dervan,et al.  Arresting cancer proliferation by small-molecule gene regulation. , 2004, Chemistry & biology.

[82]  G. Fronza,et al.  The biological effects of N3‐methyladenine , 2004, Journal of cellular biochemistry.

[83]  O. Cuvier,et al.  Displacement of D1, HP1 and topoisomerase II from satellite heterochromatin by a specific polyamide , 2006, The EMBO journal.

[84]  Y. Hiraku,et al.  Amplification of anticancer drug-induced DNA damage and apoptosis by DNA-binding compounds. , 2004, Current medicinal chemistry. Anti-cancer agents.

[85]  W. Denny,et al.  Effects of anticancer drugs on transcription factor–DNA interactions , 2005, Expert opinion on therapeutic targets.

[86]  T. C. Bruice,et al.  DNA sequence recognition in the minor groove by hairpin pyrrole polyamide-Hoechst 33258 analogue conjugate. , 2004, Bioorganic & medicinal chemistry letters.

[87]  Hans-Dieter Arndt,et al.  Minimization of a protein-DNA dimerizer. , 2007, Journal of the American Chemical Society.

[88]  R. Gellibolian,et al.  Long CCG triplet repeat blocks exclude nucleosomes: a possible mechanism for the nature of fragile sites in chromosomes. , 1996, Journal of molecular biology.

[89]  W. Denny,et al.  Structure of the d(CGCGAATTCGCG)2 Complex of the Minor Groove Binding Alkylating Agent Alkamin Studied by Mass Spectrometry , 2007, Molecular Pharmacology.

[90]  W. Denny,et al.  Minor groove binding of SN6999 to an alkylated DNA: molecular structure of d(CGC[e6G]AATTCGCG)-SN6999 complex. , 1993, Biochemistry.

[91]  J. Lown,,et al.  Bis-benzimidazole anticancer agents: targeting human tumour helicases. , 1999, Anti-cancer drug design.

[92]  W. Denny,et al.  Microbial mutagenic effects of the DNA minor groove binder pibenzimol (Hoechst 33258) and a series of mustard analogues. , 1995, Mutation research.

[93]  D. Baumann [New drugs. 9]. , 1973, Pharmazeutische Praxis.

[94]  C. Koller,et al.  Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. , 1991, The Journal of clinical investigation.

[95]  J. Griffith,et al.  Methylation of Expanded CCG Triplet Repeat DNA from Fragile X Syndrome Patients Enhances Nucleosome Exclusion* , 1996, The Journal of Biological Chemistry.

[96]  D. Boger,et al.  A fluorescent intercalator displacement assay for establishing DNA binding selectivity and affinity. , 2004, Accounts of chemical research.

[97]  B. Vig,et al.  Sequence of centromere separation: kinetochore formation in induced laggards and micronuclei. , 1986, Mutagenesis.

[98]  M. Georgiadis,et al.  A high-throughput, high-resolution strategy for the study of site-selective DNA binding agents: analysis of a "highly twisted" benzimidazole-diamidine. , 2006, Journal of the American Chemical Society.

[99]  M. Jansen,et al.  Advances in DNA-ligands with groove binding, intercalating and/or alkylating activity: chemistry, DNA-binding and biology. , 2005, Current medicinal chemistry.

[100]  J. Kovach,et al.  Phase I–II study of pibenzimol hydrochloride (NSC 322921) in advanced pancreatic carcinoma , 1991, Investigational New Drugs.

[101]  P. Dervan,et al.  Programmable DNA binding oligomers for control of transcription. , 2005, Current medicinal chemistry. Anti-cancer agents.

[102]  F. Cavalli,et al.  Phase I study of the novel distamycin derivative tallimustine (FCE 24517). , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[103]  Suman Das,et al.  N-terminal tail domains of core histones in nucleosome block the access of anticancer drugs, mithramycin and daunomycin, to the nucleosomal DNA. , 2004, Biophysical chemistry.

[104]  P. Dervan,et al.  DNA crosslinking and biological activity of a hairpin polyamide-chlorambucil conjugate. , 2003, Nucleic acids research.

[105]  P. Dervan,et al.  Sequence-specific fluorescence detection of DNA by polyamide-thiazole orange conjugates. , 2005, Journal of the American Chemical Society.

[106]  T. C. Bruice,et al.  Recognition of a 10 base pair sequence of DNA and stereochemical control of the binding affinity of chiral hairpin polyamide-Hoechst 33258 conjugates. , 2005, Bioorganic & medicinal chemistry letters.

[107]  D. Boger,et al.  A simple, high-resolution method for establishing DNA binding affinity and sequence selectivity. , 2001, Journal of the American Chemical Society.

[108]  P. Dervan,et al.  DNA Damage Effects of a Polyamide-CBI Conjugate in SV40 Virions , 2005, Molecular Pharmacology.

[109]  E. Long,et al.  Fluorescent intercalator displacement analyses of DNA binding by the peptide-derived natural products netropsin, actinomycin, and bleomycin. , 2006, Bioorganic & medicinal chemistry.

[110]  P. Aich,et al.  Role of magnesium ion in mithramycin-DNA interaction: binding of mithramycin-Mg2+ complexes with DNA. , 1995, Biochemistry.

[111]  R. Wells,et al.  DNA sequence-specific polyamides alleviate transcription inhibition associated with long GAA.TTC repeats in Friedreich's ataxia. , 2006, Proceedings of the National Academy of Sciences of the United States of America.